HENDERSON, Nev.--(BUSINESS WIRE)--Rainbow Coral Corp. (OTCBB:RBCC) partner n3D has just had an important manuscript about 3D bioprinting and cell culture screenings published in the journal Scientific Reports, a Nature publication. The article, entitled “A Spheroid Toxicity Assay Using Magnetic 3D Bioprinting and Real-Time Mobile Device-Based Imaging” describes how scientists at n3D have devised a novel assay (or test) for using 3D bioprinted cell aggregates (also known as spheroids). n3D Presi
| < Prev | Next > |
|---|
